Pasireotide Extended-Release Injection and Selegiline Transdermal System
Determining the interaction of Pasireotide Extended-Release Injection and Selegiline Transdermal System and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Selenicaps-200
- Pasireotide Extended-Release Injection-Selenimin
- Pasireotide Extended-Release Injection-Selenimin-200
- Pasireotide Extended-Release Injection-Selenious Acid
- Pasireotide Extended-Release Injection-Selenious Acid Injection
- Pasireotide Extended-Release Injection-Selenium
- Selegiline Transdermal System-Pasireotide Injection
- Selegiline Transdermal System-Pasireotide Subcutaneous
- Selegiline Transdermal System-Patanase
- Selegiline Transdermal System-Patiromer
- Selegiline Transdermal System-Patiromer Sorbitex Calcium
- Selegiline Transdermal System-Pavacot